Atlas Trials

Phase I Study of BAY73-4506 in Chinese Patients With Advanced, Refractory Solid Tumors

Clinical trial NCT01096030 · COMPLETED

Trial details

NCT number
NCT01096030
Sponsor
Bayer
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Neoplasms
Start date
2010-07-01
Primary completion
2012-11-01
Enrollment
33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.